P3 Health Partners (PIII) EBIT (2021 - 2025)

P3 Health Partners has reported EBIT for 5 years, with the latest figure at -$153.9 million in Q4 2025.

• For the quarter ending Q4 2025, EBIT fell 11.09% year-over-year to -$153.9 million; the trailing twelve-month figure through Dec 2025 stood at -$270.3 million (up 15.7% YoY), and the FY2025 full-year result was -$270.3 million, up 15.7% from the prior year.
• EBIT for Q4 2025 stood at -$153.9 million, down from -$44.2 million in the prior quarter.
• The five-year high for EBIT was $564.4 million in Q4 2021, with the low at -$912.2 million in Q2 2022.
• Historically, EBIT has averaged -$91.1 million across 5 years, with a median of -$44.0 million in 2024.
• Annual changes were most pronounced in 2022 — EBIT plunged 3412.32% — and 2023, when it soared 97.69%.
• P3 Health Partners' EBIT stood at $564.4 million in 2021, then sank by 195.07% to -$536.5 million in 2022, then jumped by 88.02% to -$64.3 million in 2023, then slumped by 115.54% to -$138.5 million in 2024, then declined by 11.09% to -$153.9 million in 2025.
• The last three EBIT figures came in at -$153.9 million (Q4 2025), -$44.2 million (Q3 2025), and -$34.1 million (Q2 2025), per Business Quant data.